Gene and Cell Therapy – Multimedia

Real-time PCR, also known as quantitative PCR (qPCR), is the gold-standard for sensitive, specific detection and quantification of nucleic acid targets and qPCR methods have become core technologies for delivering high-quality results in a range of applications throughout biologics development and biomanufacturing.

Chimeric antigen receptor (CAR) T-cell therapy is a revolutionary and promising approach for cancer treatment. However, its potential is limited by technical challenges and safety risks associated with viral transduction–based CAR T-cell generation workflows.

Speaking at the Advances in Drug Discovery & Development 2022 online symposium, Sterghios Moschos delivered his talk on targeted RNA therapeutics in the lung.

This listicle highlights five commonly used cell viability assays and their benefits and limitations in immunotherapy potency testing.

In less than 10 minutes, Professor Andrew Zydney covers: What are biopharmaceuticals? How do they differ from traditional small-molecule pharmaceuticals? How are they made? What factors might influence the high cost of biopharmaceuticals?

Download this infographic to compare traditional methods to the new precision reprogramming technology and discover its benefits.

The clinical success of CAR T-cell therapy has spurred increased interest and investments in the advanced therapeutics industry.

Download this whitepaper to learn more about improving AAV yield and purity using affinity resins as well as how affinity purification can contribute to viral clearance.

Many novel cell and gene therapies have the potential to offer personalized therapeutic approaches and hold great promise for curing or treating diseases.

In this Teach Me in 10 episode, Lucy Lawrence is joined by Dr. Eric Wengert, postdoctoral fellow at The Children’s Hospital of Philadelphia to discuss gene therapies used to treat epilepsy.